Litcius/Paper detail

TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts

Edward R. Smith, Tim D. Hewitson

2020Scientific Reports31 citationsDOIOpen Access PDF

Abstract

TGF-β1 reprograms metabolism in renal fibroblasts, inducing a switch from oxidative phosphorylation to aerobic glycolysis. However, molecular events underpinning this are unknown. Here we identify that TGF-β1 downregulates acetyl-CoA biosynthesis via regulation of the pyruvate dehydrogenase complex (PDC). Flow cytometry showed that TGF-β1 reduced the PDC subunit PDH-E1α in fibroblasts derived from injured, but not normal kidneys. An increase in expression of PDH kinase 1 (PDK1), and reduction in the phosphatase PDP1, were commensurate with net phosphorylation and inactivation of PDC. Over-expression of mutant PDH-E1α, resistant to phosphorylation, ameliorated effects of TGF-β1, while inhibition of PDC activity with CPI-613 was sufficient to induce αSMA and pro-collagen I expression, markers of myofibroblast differentiation and fibroblast activation. The effect of TGF-β1 on PDC activity, acetyl-CoA, αSMA and pro-collagen I was also ameliorated by sodium dichloroacetate, a small molecule inhibitor of PDK. A reduction in acetyl-CoA, and therefore acetylation substrate, also resulted in a generalised loss of protein acetylation with TGF-β1. In conclusion, TGF-β1 in part regulates fibroblast activation via effects on PDC activity.

Topics & Concepts

Pyruvate dehydrogenase kinasePyruvate dehydrogenase complexPyruvate dehydrogenase phosphatasePhosphorylationPKM2GlycolysisFibroblastPyruvate kinaseChemistryCell biologyAcetylationMolecular biologyBiochemistryBiologyMetabolismEnzymeIn vitroGeneParathyroid Disorders and TreatmentsEpigenetics and DNA MethylationChronic Kidney Disease and Diabetes
TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts | Litcius